SynthesisJournal of vascular surgery2021

Update on paclitaxel for femoral-popliteal occlusive disease in the 15 months following a summary level meta-analysis demonstrated increased risk of late mortality and dose response to paclitaxel.

Peter A Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.